Effects of glycopryrrolate/formoterol (Bevespi) on ventilation and gas exchange abnormalities in COPD assessed by 129Xe MRI
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
January 26, 2018
End Date
December 31, 2020
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
AstraZeneca Pharmaceuticals, LP
Start Date
January 26, 2018
End Date
December 31, 2020